GluN2B influences the progression of status epilepticus by modulating calcium ion homeostasis through its interaction

Lin Zhang1, Youshi Meng1, Chaoning Liu1

  • 1Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

PubMed
Abstract

Insights

Status epilepticus (SE) involves prolonged seizures, necessitating new treatments. This study reveals that the interaction between GluN2B and CaMKIIα impacts calcium homeostasis and seizure activity, offering potential therapeutic targets.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathophysiology

Background:

  • Status epilepticus (SE) is a neurological emergency with prolonged seizures and adverse outcomes.
  • Current pharmaceuticals are not universally effective for seizure cessation.
  • Novel therapeutic targets for SE prevention and treatment are crucial.

Purpose of the Study:

  • To assess the expression and interaction of N-methyl-D-aspartate receptor (NMDAR) subunit GluN2B and CaMKIIα in the hippocampus after epileptic convulsions.
  • To explore the potential mechanisms of action of GluN2B and CaMKIIα in SE.

Main Methods:

  • Western blotting to evaluate CaMKIIα, p-CaMKIIα, and GluN2B protein levels in the hippocampus of mice with kainic acid-induced SE.
  • Immunofluorescence colocalization and co-immunoprecipitation to investigate the GluN2B-CaMKIIα interaction.
  • Flow cytometry to measure intracellular calcium ion levels.

Main Results:

  • SE mice showed elevated hippocampal calcium levels and reduced p-CaMKIIα expression compared to sham controls.
  • CaMKIIα and GluN2B levels were unchanged, but their interaction (immune complex) significantly increased in SE mice.
  • The GluN2B inhibitor ifenprodil prolonged seizure latency, counteracted calcium influx, and modulated p-CaMKIIα and GluN2B-CaMKIIα complex levels.

Conclusions:

  • The interaction between GluN2B and CaMKIIα is critical in SE pathophysiology.
  • This interaction influences p-CaMKIIα levels and calcium ion homeostasis.
  • Reduced CaMKIIα phosphorylation, dependent on the NMDAR pathway, may disrupt calcium homeostasis and alter the excitation/inhibition balance.

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.0K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
4.9K
Feedback Regulation of Calcium Concentration01:27

Feedback Regulation of Calcium Concentration

Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
3.3K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
247
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
249
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
126